Diabetic Neuropathy
Table of Contents (click to jump to sections)
What is Diabetic Neuropathy?Is there any treatment?What is the prognosis?What research is being done?Organizations
Additional resources from MEDLINEplus
What is Diabetic Neuropathy?
Diabetic neuropathy is a peripheral nerve disorder caused by diabetes. The symptoms of diabetic neuropathy are often slight
at first. In fact, some mild cases may go unnoticed for a long time. Numbness, pain, or tingling in the feet, or legs may,
after several years, lead to weakness in the muscles of the feet. Occasionally, diabetic neuropathy can flare up suddenly
and affect specific nerves so that an affected individual will develop double vision or drooping eyelids, or weakness and
atrophy of the thigh muscles. Nerve damage caused by diabetes generally occurs over a period of years and may lead to problems
with the digestive tract and sexual organs, which can cause indigestion, diarrhea or constipation, dizziness, bladder infections,
and impotence. The loss of sensation in the feet may increase the possibility for foot injuries to go unnoticed and develop
into ulcers or lesions that become infected.
Is there any treatment?
The goal of treating diabetic neuropathy is to relieve discomfort and prevent further tissue damage. The first step is to
bring blood sugar levels under control by diet and medication. Another important part of treatment involves taking special
care of the feet. Analgesics, low doses of antidepressants, and some anticonvulsant medications may be prescribed for relief
of pain, burning, or tingling. Some patients may find that walking regularly, taking warm baths, or using elastic stockings
may help relieve leg pain.
What is the prognosis?
The prognosis for diabetic neuropathy depends largely on how well the underlying condition of diabetes is handled. Treating
diabetes may halt progression and improve symptoms of the neuropathy, but recovery is slow. The painful sensations of diabetic
neuropathy may become severe enough to cause depression in some patients.
What research is being done?
The NINDS conducts and supports research on diabetic neuropathy to increase understanding of the disorder and find ways to
prevent and cure it. New medications are currently being examined to assess improvement or stabilization of neuropathic symptoms.
Select this link
to view a list of studies currently seeking patients.
Organizations
American Chronic Pain Association (ACPA)
P.O. Box 850
Rocklin,
CA
95677-0850
ACPA@pacbell.net
http://www.theacpa.org
Tel: 916-632-0922
800-533-3231
Fax: 916-632-3208
|
American Diabetes Association
1701 North Beauregard Street
Alexandria,
VA
22311
askada@diabetes.org
http://www.diabetes.org
Tel: 800-DIABETES (342-2383)
703-549-1500
|
Juvenile Diabetes Research Foundation, International
120 Wall Street
New York,
NY
10005-4001
info@jdrf.org
http://www.jdrf.org
Tel: 800-533-CURE (-2873)
212-785-9500
Fax: 212-795-9595
|
National Institute of Dental and Craniofacial
Research (NIDCR)
National Institutes of Health, DHHS
31 Center Drive, Room 5B-55
Bethesda,
MD
20892
nidcrinfo@mail.nih.gov
http://www.nidcr.nih.gov
Tel: 301-496-4261
|
National Institute of Diabetes and Digestive
and Kidney Diseases (NIDDK)
National Institutes of Health, DHHS
31 Center Drive, Rm. 9A06 MSC 2560
Bethesda,
MD
20892-2560
http://www.niddk.nih.gov
Tel: 301-496-3583
|
|
Prepared by:
Office of Communications and Public Liaison
National Institute of Neurological Disorders and Stroke
National Institutes of Health
Bethesda, MD 20892
NINDS health-related material is provided for information purposes only and does not necessarily represent endorsement by
or an official position of the National Institute of Neurological Disorders and Stroke or any other Federal agency. Advice
on the treatment or care of an individual patient should be obtained through consultation with a physician who has examined
that patient or is familiar with that patient's medical history.
All NINDS-prepared information is in the public domain and may be freely copied. Credit to the NINDS or the NIH is appreciated.
Return to top
Last updated February 12, 2007
